
Reata Pharmaceuticals (RETA)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy Reata Pharmaceuticals (RETA) Stock
Start investing in Reata Pharmaceuticals (RETA)
About Reata Pharmaceuticals (RETA)
Market cap | $6.57B |
Today's volume | — |
Revenue (TTM) | — |
Avg. daily volume | 908.34K |
EBITDA (TTM) | — |
Open | — |
Price / earnings ratio | -57.67x |
Today's range | — |
Debt / equity | — |
52 week range | $21.83 - $172.46 |
5 year debt / equity | 32.12x |
Beta (LTM) | 0.58x |
Interest coverage | — |
Dividend & yield | $0.00 (0.00%) |
Current ratio | — |
Ex-dividend date | — |
Next earnings | Dec 31, 2024 |
Dividend payable date | — |
Reata Pharmaceuticals Stock Rating
Reata Pharmaceuticals Stock News
View all



Frequently Asked Questions (FAQ)
How to buy RETA stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in RETA stock
Navigate to the Explore page. Then, type RETA into the search bar. When you see RETA stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased RETA stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Reata Pharmaceuticals Stock Earnings
The value each RETA share was expected to gain vs. the value that each RETA share actually gained.
Reata Pharmaceuticals (RETA) reported Q2 2023 earnings per share (EPS) of -$1.58, beating estimates of -$2.09 by 24.40%. In the same quarter last year, Reata Pharmaceuticals's earnings per share (EPS) was -$1.36. Reata Pharmaceuticals is expected to release next earnings on 12/31/2024, with an earnings per share (EPS) estimate of $0.